Corbus Pharmaceuticals (CRBP) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-2.16
-1.71
-1.27
-0.83

Details

Expected EPS
-0.951937
Actual EPS
-1.15
Surprise EPS
-0.2
Surprise Percent
+20.81%

Description

Corbus Pharmaceuticals (CRBP) has reported earnings of -1.15 per share for Q4 2024.

0 Comments

Share your thoughts